Covered recipient · General Payments record
MAGALY VILLAFRADEZ-DIAZ
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2018–2024
$15,701.42
- Reported across 885 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $666.42 | 36 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $165.69 | 9 |
| UCB, Inc. | $137.40 | 8 |
| GlaxoSmithKline, LLC. | $99.13 | 5 |
| PFIZER INC. | $88.97 | 4 |
| Amgen Inc. | $88.75 | 5 |
| Mallinckrodt Hospital Products Inc. | $50.02 | 3 |
| GENZYME CORPORATION | $18.50 | 1 |
| Genentech USA, Inc. | $17.96 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (36)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.89 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106284696 | CMS |
| ABBVIE INC. | $18.49 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106284698 | CMS |
| ABBVIE INC. | $14.03 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106284700 | CMS |
| ABBVIE INC. | $24.37 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106284702 | CMS |
| ABBVIE INC. | $17.03 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106284704 | CMS |
| ABBVIE INC. | $20.86 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106284706 | CMS |
| ABBVIE INC. | $14.02 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106284708 | CMS |
| ABBVIE INC. | $7.97 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106284710 | CMS |
| ABBVIE INC. | $30.03 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106284712 | CMS |
| Amgen Inc. | $13.22 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117407254 | CMS |
| Amgen Inc. | $18.36 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111733741 | CMS |
| Amgen Inc. | $16.98 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111733745 | CMS |
| Amgen Inc. | $24.12 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117710088 | CMS |
| Amgen Inc. | $16.07 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111733743 | CMS |
| Genentech USA, Inc. | $17.96 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133058000 | CMS |
| GENZYME CORPORATION | $18.50 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139834470 | CMS |
| GlaxoSmithKline, LLC. | $18.63 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116699747 | CMS |
| GlaxoSmithKline, LLC. | $23.19 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116472319 | CMS |
| GlaxoSmithKline, LLC. | $17.64 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116694835 | CMS |
| GlaxoSmithKline, LLC. | $18.10 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115988141 | CMS |
| GlaxoSmithKline, LLC. | $21.57 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115946079 | CMS |
| Mallinckrodt Hospital Products Inc. | $18.68 | 01/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145149847 | CMS |
| Mallinckrodt Hospital Products Inc. | $13.61 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145149851 | CMS |
| Mallinckrodt Hospital Products Inc. | $17.73 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145149855 | CMS |
| PFIZER INC. | $17.13 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131289209 | CMS |
| PFIZER INC. | $23.76 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131499255 | CMS |
| PFIZER INC. | $24.30 | 09/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131960006 | CMS |
| PFIZER INC. | $23.78 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131144921 | CMS |
| UCB, Inc. | $18.10 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143469362 | CMS |
| UCB, Inc. | $25.10 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143469367 | CMS |
| UCB, Inc. | $17.30 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143469371 | CMS |
| UCB, Inc. | $27.85 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143469376 | CMS |
| UCB, Inc. | $18.43 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143469380 | CMS |
| UCB, Inc. | $8.93 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143469385 | CMS |
| UCB, Inc. | $5.85 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143469389 | CMS |
| UCB, Inc. | $15.84 | 11/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143469394 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.